Inspection outcomes are shaped long before inspection. We align facility design, engineering, quality systems, validation, and technology transfer around clear regulatory intent from the earliest decisions.
What we do
Our services connect engineering, compliance, quality, and validation so each decision supports a facility that is ready for operation and inspection.
Design & Engineering Consulting
01
We support concept to detailed design for pharmaceutical facilities, aligning layouts, HVAC strategy, cleanroom systems, utilities, and process requirements before decisions harden.
Concept and detailed design advisory
HVAC and cleanroom strategy
Process, utility, and system intent
Regulatory Compliance
02
We interpret EU-GMP, USFDA, WHO-GMP, PIC/S, ICH, and market-specific expectations so zoning, segregation, flows, and documentation carry a clear rationale.
Gap assessments and audit readiness
Zoning, segregation, and flow strategy
Regulatory rationale for design decisions
Qualification & Validation
03
Validation is integrated early so qualification logic, system boundaries, and evidence pathways remain predictable through DQ, IQ, OQ, and process validation.
VMP, PVP, RA, and URS strategy
DQ, IQ, and OQ alignment
Qualification and validation logic
QMS Development
04
We structure SOP systems, CAPA, deviation management, governance, and lifecycle controls so quality expectations remain coherent under operation and inspection.
SOP and QMS frameworks
CAPA and deviation systems
Lifecycle management controls
Technology Transfer
05
We support process transfer, scale-up, BMR and BPR alignment, and validation strategy so product, process, and facility decisions move together.
Process transfer and scale-up support
BMR and BPR alignment
Validation strategy for transfer
Inspection Readiness
06
We help teams maintain continuity between design logic, quality systems, documentation, validation, and audit preparation so the facility remains inspection-ready.
Pre and post audit readiness
Aligned documentation narrative
Operational readiness checks
Regulatory alignment
Compliance is not applied as a final layer. We define the relevant markets, agencies, and expected scrutiny before engineering decisions are finalised.
EU-GMP
WHO-GMP
ICH Guidelines
EU-GMP
WHO-GMP
ICH Guidelines
EU-GMP
WHO-GMP
ICH Guidelines
EU-GMP
WHO-GMP
ICH Guidelines
Areas of expertise
Our approach adapts to the process, contamination risk, operating model, and inspection expectations of each facility type.
01
Facilities structured around product, people, material, and containment logic.
02
Cleanroom, contamination-control, and validation decisions aligned early.
03
Complex process and risk boundaries translated into defensible infrastructure.
How we engage
Each stage builds toward regulatory confidence and operational clarity, removing ambiguity early and preserving intent through inspection readiness.
We define markets, agencies, GMP expectations, process risks, and project boundaries before critical engineering decisions are fixed.
Facility layouts, zoning, flows, HVAC strategy, cleanroom systems, and utilities are integrated with process and compliance intent.
Qualification logic, VMP, URS, risk assessment, QMS frameworks, and documentation structures are aligned before execution pressure arrives.
We support technology transfer, lifecycle controls, BMR and BPR alignment, and go-live readiness so operations inherit clear systems.
Design rationale, quality systems, validation evidence, and audit preparation are brought together into a coherent inspection narrative.
Outcomes
We help facilities move from first decision to final inspection with regulatory intent, engineering logic, quality systems, and validation evidence still connected.
01
Clear design logic for zoning, segregation, flows, systems, and documentation
02
Stronger alignment between engineering, quality, validation, and operations
03
Reduced downstream risk from late regulatory interpretation or design drift
04
A coherent inspection narrative supported by evidence and operational controls
Engagement context
Oral solid dosage facilities
Injectable and sterile facilities
High-containment and advanced therapy facilities
Greenfield, brownfield, transfer, scale-up, and market-expansion programs
Get in touch
Tell us about your facility — where it's going, what it needs to achieve. We'll tell you where the structural risks are.
Lets talk